Results 171 to 180 of about 85,807 (301)

Characterizing multimorbidity and the risk for hospitalization among people living with HIV from the African Cohort Study. [PDF]

BMC Glob Public Health
Scott R, Olsen CH, Crowell TA, Mancuso JD, Kibuuka H, Maswai J, Owuoth J, Sing'oei V, Bahemana E, Parker Z, Ake JA, Shah N, Lee EH.   +12 more
europepmc   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

The impact of multimorbidity on foot health outcomes in podiatry patients with musculoskeletal foot pain: a prospective observational study [PDF]

, 2019
Fenocchi, Linda, Hendry, Gordon J., Mason, Helen, Steultjens, Martijn   +3 more
core  

Perinatal Exposures Are Related to Atopic Symptom Development in Early Childhood

Clinical &Experimental Allergy, EarlyView.
Gina J. van Beveren, Nynke L. Harschel, Erik Tieken, Sjoerd M. Euser, Frans B. Plötz, Wouter J. de Waal, Ivo van der Lee, Suzanne W. J. Terheggen‐Lagro, Marlies A. van Houten, Debby Bogaert   +9 more
wiley   +1 more source

Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States (SMILE)

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the real‐world associations between semaglutide 2.4 mg and cardiometabolic comorbidities, biomarkers and cardiovascular risk among adults with overweight or obesity. Methods This retrospective cohort study used US claims data and laboratory measurements from the Komodo Research Database (2016–2024). Adults with obesity or with
Aleksandrina Ruseva, Wojciech Michalak, Matthew Bassan, Ella Xiaoyan Du, Anthony Fabricatore, Bríain Ó Hartaigh, Theo Man, Ramya Ramasubramanian, Pangsibo Shen, Jinlin Song, Zhenxiang Zhao, Francisco Lopez‐Jimenez   +11 more
wiley   +1 more source

Adverse childhood and adult experiences, intrinsic capacity decline, and subsequent physical-psychological-cognitive multimorbidity: a prospective cohort study from China. [PDF]

J Nutr Health Aging
Liu K, Luo H, E B, Kuang H, Zhang C, Guo X.   +5 more
europepmc   +1 more source

Racial Differences in Patterns of Long‐Term Conditions Among Adults With Asthma

Clinical &Experimental Allergy, EarlyView.
Sang Hyuk Kim, Seung Park, Sungmin Zo, Tae‐Hyung Kim, Sang‐Heon Kim, Jae Jeong Shim, Hyun Lee, Kyung Hoon Min   +7 more
wiley   +1 more source

Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Asthma and diabetes frequently co‐occur and share metabolic and inflammatory features, yet the cardiometabolic profile associated with their coexistence is not well defined. We examined differences in cardiometabolic and inflammatory biomarkers by joint asthma–diabetes status in U.S.
Sixtus Aguree, Patricia Silveyra, Nianjun Liu, Arthur H. Owora, Tesfaye B. Mersha   +4 more
wiley   +1 more source

Multiprofessional and multidisciplinary teleconsultation for the management of multimorbidity: preliminary results from the joint action JADECARE. [PDF]

BMC Health Serv Res
Ferravante C, Rimmele M, Gütter Z, Paolo Francesconi on behalf of Next Adopter Working Group.   +3 more
europepmc   +1 more source

Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Young adults (aged ≤ 40 years) are underrepresented in clinical trials that investigate interventions for those living with Type 2 diabetes (T2D). This study evaluated the efficacy of semaglutide treatment in young adults with T2D by examining the effects on HbA1c and body weight (BW) during the SUSTAIN and PIONEER programmes compared to ...
Francesco Zaccardi, Vanita R. Aroda, Ecenur Guder Arslan, Lars Bardtrum, Jonathan Goldney, Erik Ising, Prachi Priyadarshini, Tommy Slater, Melanie J. Davies   +8 more
wiley   +1 more source